Most importantly, our observation that USP22 knockdown impairs human cancer cell growth and tumor formation suggests that USP22 is involved in tumorigenesis, implying a great therapeutic potential of USP22 suppression in colon cancer treatment. This evidence concerns the gene USP22 and colonic neoplasm.